Pulmonary: Page 4

Ralinepag may redefine PAH treatment approach
The once-daily, oral prostacyclin agonist demonstrated statistically significant efficacy in phase 3 study.
May 28, 2026
Anatomical lung model surrounded by white pharmaceutical capsules and pills on pink background
Lungs coordinate response to immune threats
Researchers determine the barrier organ has a multilevel reaction to inhaled viruses and noninfectious particles.
May 22, 2026
Illustration of human silhouette with lungs surrounded by virus particles on colorful background
Pulmonary rehab reaps benefits for pediatric patients
Children who have chronic respiratory conditions can significantly improve function and quality of life.
May 21, 2026
Female pediatrician assisting young boy with nebulizer treatment in clinic with children's artwork on wall
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary drug market forecast
Cutting-edge pneumonia classification
Scientists analyzed human lungs to uncover seven subgroups of the widespread respiratory disease.
May 14, 2026
Histopathological tissue sample showing H&E stained cellular structures with glandular formations and inflammatory infiltrate
Infectious bacteria observed in chronic lung, sinus diseases
People with both conditions are at increased risk of Pseudomonas aeruginosa — a persistent bacteria.
May 14, 2026
Woman in yellow sweater and glasses coughing with hand to chest in bright home interior
A potential cure for severe CF mutation
Gene editing therapy could be the ultimate solution for patients with a difficult-to-treat form of cystic fibrosis.
May 7, 2026
DNA strand being edited with a precision tool, representing genetic engineering and biotechnology research
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary drug market forecast
Exploration of lung scarring reversal
An experimental drug targeting ID1 and ID3 could both halt and undo damage caused by pulmonary fibrosis.
May 5, 2026
Three laboratory scientists in white coats and blue gloves examining samples in a research facility.
Lung scan differences help signal sarcoidosis severity
Analytic findings could lead to improved classification, disease prediction and personalized care plans.
May 1, 2026
Chest CT scan comparison showing axial cross-sections of lungs with bilateral parenchymal patterns labeled A and B
A new target to alleviate PAH
Japanese scientists demonstrated the role of CNP/GC-B signaling and suggest supplemental therapy to prevent or slow disease progression.
April 29, 2026
Diagram showing normal pulmonary arterioles versus PAH progression, illustrating endothelial proliferation, smooth muscle thickening, and CNP treatment mechanisms with GC-B signaling pathways.
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
Pulmonary fibrosis insight
Hiding in plain sight
Research reveals how rare lung cancers with mixed tumor features can progress and transform.
April 23, 2026
Digital illustration of lungs with airway network and magnified view of cancer cells
Human airway models could pave way for improved devices, therapies
A computational study illustrates the need for patient-specific modeling to treat certain pulmonary conditions.
April 23, 2026
Doctor demonstrating human respiratory system anatomy model with lungs and airways highlighted in pink
Inhaled treprostinil reduces FVC decline
Trial meets primary and secondary endpoints in the treatment of idiopathic pulmonary fibrosis in adults.
April 17, 2026
Person in pink shirt holding clear acrylic physics demonstration device with suspended colored spheres
Previous Page
Page 4 of 29
Next Page
Most Popular
Is there a ‘window of opportunity’ for biologic treatment in severe asthma?
FDA approves study of inhaled stem cell therapy for COPD
Semaglutide significantly lowers asthma, COPD attacks
Common cold: There may be a vaccine for that
Novel inhaled treatment for COPD shows promise in clinical trial
MRI reduces cognitive failure, adverse events in SCLC